Corrigendum: Discoidin Domain Receptors: Potential Actors and Targets in Cancer

Hassan Rammal, Charles Saby, Kevin Magnien, Laurence Van-Gulick, Roselyne Garnotel, Emilie Buache, Hassan El Btaouri, Pierre Jeannesson, Hamid Morjani, Hassan Rammal, Charles Saby, Kevin Magnien, Laurence Van-Gulick, Roselyne Garnotel, Emilie Buache, Hassan El Btaouri, Pierre Jeannesson, Hamid Morjani

Abstract

[This corrects the article on p. 55 in vol. 7, PMID: 27014069.].

Keywords: cancer; cell signaling; collagen; discoidin domain receptors; extracellular matrix; targeted therapy; tyrosine kinase.

References

    1. Borza C. M., Pozzi A. (2014). Discoidin domain receptors in disease. Matrix Biol. 34, 185–192. 10.1016/j.matbio.2013.12.002
    1. Carafoli F., Hohenester E. (2013). Collagen recognition and transmembrane signalling by discoidin domain receptors. Biochim. Biophys. Acta 1834, 2187–2194. 10.1016/j.bbapap.2012.10.014
    1. Fu H. L., Valiathan R. R., Arkwright R., Sohail A., Mihai C., Kumarasiri M., et al. . (2013). Discoidin domain receptors: unique receptor tyrosine kinases in collagen-mediated signaling. J. Biol. Chem. 288, 7430–7437. 10.1074/jbc.R112.444158
    1. Hodge J. W., Ardiani A., Farsaci B., Kwilas A. R., Gameiro S. R. (2012). The tipping point for combination therapy: cancer vaccines with radiation, chemotherapy, or targeted small molecule inhibitors. Semin. Oncol. 39, 323–339. 10.1016/j.phrs.2015.07.010
    1. Iwai L. K., Payne L. S., Luczynski M. T., Chang F., Xu H., Clinton R. W., et al. . (2013). Phosphoproteomics of collagen receptor networks reveals SHP-2 phosphorylation downstream of wild-type DDR2 and its lung cancer mutants. Biochem. J. 454, 501–513. 10.1042/BJ20121750
    1. Kwilas A.R., Donahue R.N., Bernstein M.B., Hodge J.W. (2012). In the field: exploiting the untapped potential of immunogenic modulation by radiation in combination with immunotherapy for the treatment of cancer. Front. Oncol. 2:104. 10.3389/fonc.2012.00104
    1. Leitinger B. (2014). Discoidin domain receptor functions in physiological and pathological conditions. Int. Rev. Cell Mol. Biol. 310, 39–87. 10.1016/B978-0-12-800180-6.00002-5
    1. Marquez J., Olaso E. (2014). Role of discoidin domain receptor 2 in wound healing. Histol. Histopathol. 29, 1355–1364. 10.14670/HH-29.1355
    1. Ramos P., Bentires-Alj M. (2015). Mechanism-based cancer therapy: resistance to therapy, therapy for resistance. Oncogene 34, 3617–3626. 10.1038/onc.2014.314
    1. Ren T., Zhang W., Liu X., Zhao H., Zhang J., Zhang J., et al. . (2014). Discoidin domain receptor 2 (DDR2) promotes breast cancer cell metastasis and the mechanism implicates epithelial-mesenchymal transition programme under hypoxia. J. Pathol. 234, 526–537. 10.1002/path.4415
    1. Semenova E. A., Nagel R., Berns A. (2015). Origins, genetic landscape, and emerging therapies of small cell lung cancer. Genes Dev. 29, 1447–1462. 10.1101/gad.263145.115
    1. Valiathan R. R., Marco M., Leitinger B., Kleer C. G., Fridman R. (2012). Discoidin domain receptor tyrosine kinases: new players in cancer progression. Cancer Metastasis Rev. 31, 295–321. 10.1007/s10555-012-9346-z

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅